ST. PAUL, Minn., Jan. 30, 2017 /PRNewswire-USNewswire/ -- St. Teresa Medical launches its new website today developed by Concept Design group. The new website describes St. Teresa's revolutionary SURGICLOT® product which incorporates the FASTCLOT® hemostasis technology and the important role it will play in changing how spine and orthopedic surgeries are performed. SURGICLOT is the only hemostasis agent that dissolves and resorbs as it creates a natural fibrin clot to stop bleeding during surgery. Further it shrinks in volume as it works making it ideal for use in and around delicate anatomies like the spine.
St. Teresa Medical has successfully completed 2 clinical trials testing SURGICLOT in treating cancellous bone bleeding during orthopedic procedures in the United Kingdom, Norway and India. SURGICLOT is currently in process for CE Mark registration in the European Union. Once approved it will be the only fibrin based hemostatic agent specifically labeled for treating cancellous bone bleeding.
Concept Design Group is a Wisconsin and Florida-based company specializing in web development, SEO and social media.
About St. Teresa
St. Teresa Medical, Inc.®, based in St. Paul, Minn., is a medical-device company developing a new unique dissolvable hemostatic dressing called SURGICLOT®.
For more information, see www.StTeresaMedical.com or contact Brian Jackson, CFO at 651-789-4633.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/st-teresa-medical-launches-new-state-of-the-art-website-wwwstteresamedicalcom-300398745.html
SOURCE St. Teresa Medical, Inc.